tiprankstipranks
Trending News
More News >
Marker Therapeutics (MRKR)
:MRKR
US Market

Marker Therapeutics (MRKR) Technical Analysis

Compare
530 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Marker Therapeutics’s (MRKR) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Marker Therapeutics is a Buy.
Marker Therapeutics’s (MRKR) 20-Day exponential moving average is 1.50, while Marker Therapeutics’s (MRKR) share price is $1.6, making it a Buy.
Marker Therapeutics’s (MRKR) 50-Day exponential moving average is 1.44, while Marker Therapeutics’s (MRKR) share price is $1.6, making it a Buy.

Marker Therapeutics (MRKR) Pivot Points

Jul 07, 2025, 06:40 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.46
1.49
1.53
1.55
1.59
1.62
1.66
Fibonacci
1.49
1.51
1.53
1.55
1.58
1.59
1.62
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Marker Therapeutics (MRKR) Moving Averages

Jul 07, 2025, 06:40 PM
Period
Simple
Exponential
MA5
1.53Buy
1.55Buy
MA10
1.49Buy
1.53Buy
MA20
1.56Buy
1.50Buy
MA50
1.36Buy
1.44Buy
MA100
1.35Buy
1.61Sell
MA200
2.26Sell
2.33Sell
Marker Therapeutics’s (MRKR) 10-Day exponential moving average is 1.53, while Marker Therapeutics’s (MRKR) share price is $1.6, making it a Buy.
Marker Therapeutics’s (MRKR) 100-Day exponential moving average is 1.61, while Marker Therapeutics’s (MRKR) share price is $1.6, making it a Sell.
Marker Therapeutics’s (MRKR) stock price is $1.6 and Marker Therapeutics’s (MRKR) 50-day simple moving average is 1.36, creating a Buy signal.
Marker Therapeutics’s (MRKR) stock price is $1.6 and Marker Therapeutics’s (MRKR) 100-day simple moving average is 1.35, creating a Buy signal.
Marker Therapeutics’s (MRKR) stock price is $1.6 and Marker Therapeutics’s (MRKR) 200-day simple moving average is 2.26, creating a Sell signal.

Marker Therapeutics (MRKR) Technical Indicators

Jul 07, 2025, 06:40 PM
Name
Value
Implied Action
RSI (14)
58.66
Neutral
STOCH (9,6)
82.33
Sell
STOCHRSI (14)
37.68
Neutral
MACD (12,26)
0.04
Buy
ADX (14)
34.17
Neutral
Williams %R
-40.62
Buy
CCI (14)
27.87
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
47.46
Neutral
ROC
-5.33
Sell
Marker Therapeutics’s (MRKR) Relative Strength Index (RSI) is 58.66, creating a Neutral signal.
Marker Therapeutics’s (MRKR) Trend Strength Indicator (ADX) is 34.17, creating a Neutral signal.
Marker Therapeutics’s (MRKR) Commodity Channel Index (CCI) is 27.87, creating a Neutral signal.
Marker Therapeutics’s (MRKR) Price Rate of Change (ROC) is -5.33, creating a Sell signal.

FAQ

Is MRKR a Buy, Hold, or Sell?
Based on MRKR’s technical indicators, MRKR is a Buy.
    What is MRKR’s RSI (14)?
    MRKR’s RSI (14) is 58.66, which suggests MRKR is a Neutral.
      What is MRKR’s MACD?
      MRKR’s MACD is 0.04, which suggests MRKR is a Buy.
        What is MRKR’s 5-day moving average?
        MRKR’s 5-day moving average is 1.53, which suggests MRKR is a Buy.
          What is MRKR’s 20-day moving average?
          MRKR 20-day moving average is 1.56, which suggests MRKR is a Buy.
            What is MRKR’s 50-day moving average?
            MRKR’s 50-day moving average is 1.36, which suggests MRKR is a Buy.
              What is MRKR’s 200-day moving average?
              MRKR’s 200-day moving average is 2.26, which suggests MRKR is a Sell.
                What is MRKR’s Williams % R (14)?
                MRKR’s Williams % R (14) is -40.62, which suggests MRKR is a Buy.
                  What is MRKR’s CCI (14)?
                  MRKR’s CCI (14) is 27.87, which suggests MRKR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis